Cargando…
The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea
INTRODUCTION: Clozapine is a second-generation antipsychotic indicated in treatment-resistant schizophrenia. Patients taking clozapine are likely to experience an increase in salivation or sialorrhea. Clozapine‐induced sialorrhea (CIS) may lead to sleep disturbances or aspiration pneumonia. Treatmen...
Autor principal: | Darriba, H. Becerra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480043/ http://dx.doi.org/10.1192/j.eurpsy.2021.2061 |
Ejemplares similares
-
The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
por: Van der Poorten, Thomas, et al.
Publicado: (2019) -
Dealing With Clozapine-Induced Sialorrhea
por: Sá Couto, J., et al.
Publicado: (2022) -
Examining the Role of Sublingual Atropine for the Treatment of Sialorrhea in Patients with Neurodevelopmental Disabilities: A Retrospective Review
por: Petkus, Kayla Durkin, et al.
Publicado: (2023) -
Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
por: Darriba, H. Becerra
Publicado: (2021) -
Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea
por: Leung, Jonathan G., et al.
Publicado: (2020)